HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Distributing Health, Beauty Products To Retailers, Hims & Hers Seeds Field For OTC ED Drug Sales

Executive Summary

With ED ingredients frequently mentioned as OTC switch candidates in US, Hims & Hers Health is another latest direct-to-consumer marketer establishing network of retailers to offer potential OTC ED drug as it makes its consumer health and personal care products available in stores.

You may also be interested in...



Telehealth Firm Ro Talks More Than ED But Still DTC With Further Consumer Health Expansion

Ro acquires Dadi  specializing in sperm testing, analysis and storage, two weeks after adding $150m funding and 10 months after entering female fertility product market with acquisition of Modern Fertility.

No OTC Sildenafil In Germany After Committee Rejects All Rx-To-OTC Switches

The German Expert Committee for Prescription has rejected the Rx-to-OTC reclassifications of sildenafil (50mg) for oral use and xylometazoline and ipratropium bromide for intranasal use. 

Petros Includes Nitrate Patients In OTC ED Drug Self-Selection Studies

Firms also notes in its announcement that FDA typically requires actual use trials for switch NDAs in addition to label comprehension studies, which it has conducted, and self-selection studies.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS152222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel